文献速递脑血管病外科神经重症

单种干预与Spetzler-Martin I-II级动静脉畸形长期结局的关联:全国多中心前瞻性观察队列研究

Association of monotherapy intervention with long-term outcomes in Spetzler-Martin grade I and II arteriovenous malformations: a nationwide multicenter observational prospective cohort study.
PubMed 文献 · J Neurosurg · 2026-05-01

该研究基于全国多中心前瞻性注册队列,纳入1013例SM I-II级脑动静脉畸形患者,比较保守管理与单种干预的长期出血性卒中和死亡风险。干预组发生率低于保守组(0.43 vs 0.88/100患者年;aHR 0.61,95%CI 0.24-1.52),但差异未达统计学显著。分层分析显示切除可能使未破裂和破裂AVM均获益,SRS可能仅使破裂AVM获益。

要点

  • 干预组长期出血性卒中或死亡发生率数值低于保守组,但未达统计学显著。
  • 切除可能使未破裂和破裂SM I-II级AVM均获益。
  • SRS可能仅对破裂AVM有益,栓塞和SRS对未破裂低级别AVM可能无益。

核心结论

  • 在SM I-II级AVM中,干预在预防长期出血性卒中或死亡方面优于保守管理。
  • 切除对未破裂和破裂SM I-II级AVM均有利,SRS可能为破裂病例的合理替代。

研究设计与样本

  • 全国多中心前瞻性协作注册队列研究,纳入2011年8月至2021年12月间接受保守管理或单种干预的AVM患者。
  • 共1013例符合纳入标准,其中未破裂AVM 387例,破裂AVM 626例。

主要发现

  • 干预组与保守组长期出血性卒中或死亡发生率分别为0.43 vs 0.88/100患者年(aHR 0.61,95%CI 0.24-1.52),差异无统计学意义。
  • 未破裂AVM亚组aHR 0.95(95%CI 0.28-3.18),破裂AVM亚组aHR 0.29(95%CI 0.06-1.32)。
  • 切除对未破裂AVM有益(0.00 vs 0.79/100患者年,p=0.006),对破裂AVM亦有益(aHR 0.12,95%CI 0.03-0.53,p=0.033)。
  • SRS可能仅对破裂AVM有益(aHR 0.04,95%CI 0.01-0.34,p=0.163)。
  • 栓塞和SRS对未破裂低级别AVM可能无益。

关键数值与推荐

  • SM I-II级AVM干预组长期出血性卒中或死亡发生率为0.43/100患者年,保守组为0.88/100患者年。
  • 切除对未破裂AVM:0.00 vs 0.79/100患者年,p=0.006;对破裂AVM:aHR 0.12(95%CI 0.03-0.53),p=0.033。
  • SRS对破裂AVM:aHR 0.04(95%CI 0.01-0.34),p=0.163。

临床怎么用

  • SM I-II级AVM治疗决策需权衡干预获益与风险,干预可能降低长期出血性卒中或死亡风险。
  • 对未破裂和破裂SM I-II级AVM,切除可能是优先考虑的单种干预方式。
  • 对破裂SM I-II级AVM,SRS可作为切除之外的合理替代选择。
  • 对未破裂低级别AVM,栓塞和SRS可能不作为推荐的单种干预策略。

局限性

  • 观察性研究设计,干预组与保守组间可能存在选择偏倚。
  • 总体干预效果及部分亚组比较未达统计学显著,结果需谨慎解读。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of this study was to compare the long-term risk of hemorrhagic stroke and death between conservative management and monotherapy intervention in patients with Spetzler-Martin (SM) grade I and II brain arteriovenous malformations (AVMs). METHODS: The authors included AVMs that underwent conservative management and monotherapy intervention between August 2011 and December 2021 from a nationwide multicenter prospective collaboration registry. Patients were categorized into unruptured and ruptured cohorts for comparison of long-term outcomes, with hemorrhagic stroke and death defined as primary outcomes and neurological status as a secondary outcome. The efficacy of various intervention strategies, including resection, embolization, and stereotactic radiosurgery (SRS), was also evaluated. Stratified analyses based on intervention strategies and different SM grade subtypes were conducted. RESULTS: Of 4286 AVMs in the registry, 1013 patients were eligible for inclusion (387 with unruptured AVMs and 626 with ruptured AVMs). Overall, the intervention group showed a lower incidence of long-term hemorrhagic stroke and death compared with the conservative management group (0.43 vs 0.88 per 100 patient-years; adjusted HR [aHR] 0.61 [95% CI 0.24-1.52]), although this difference did not reach statistical significance. The results were similar in the two subgroups: aHR 0.95 (95% CI 0.28-3.18) for unruptured AVMs and aHR 0.29 (95% CI 0.06-1.32) for ruptured AVMs. Stratified analyses based on different intervention strategies and different SM grade subtypes showed that resection might benefit both unruptured (0.00 vs 0.79 per 100 patient-years, p = 0.006) and ruptured (aHR 0.12 [95% CI 0.03-0.53], p = 0.033) AVMs, while SRS might only benefit ruptured AVMs (aHR 0.04 [95% CI 0.01-0.34], p = 0.163). Embolization and SRS might not be beneficial for unruptured low-grade AVMs. CONCLUSIONS: In this observational prospective cohort study, intervention demonstrated benefit over conservative management in preventing long-term hemorrhagic stroke or death in patients with SM grade I or II AVMs. Among specific monotherapy interventions, resection proved favorable for both unruptured and ruptured SM grade I and II AVMs, while SRS might serve as a reasonable alternative in ruptured cases.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Yuan K, Li Z, Zhang H, et al. Association of monotherapy intervention with long-term outcomes in Spetzler-Martin grade I and II arteriovenous malformations: a nationwide multicenter observational prospective cohort study. J Neurosurg. 2026. PMID: 42066362. doi:10.3171/2025.12.JNS252197

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。